title: MALDI-TOF MS analysis of urinary nucleosides.
abstract: As RNA turnover seems to be impaired in cancer patients, modified nucleosides have been evaluated as potential tumor markers. Modified nucleosides are mainly formed post-transcriptionally in tRNA, set free during RNA metabolism, and excreted in urine. Especially methylated nucleosides play an important role, as their levels are higher in urine from cancer patients. For structural elucidation of known and unknown nucleosides from urine samples of cancer patients, MALDI-TOF MS and MALDI-PSD were used for the first time. This technique generally ensures high sensitivity, mass resolution, and accuracy. In our analytical approach we prepurified nucleosides from urine by affinity chromatography and subsequently separated them by semipreparative high performance liquid chromatography. The different fractions were collected separately and analyzed by MALDI-TOF MS and PSD-MALDI using a mixture of six low molecular weight calibrants for internal or external calibration. The molecular totals formulas based on a mass accuracy of 10 ppm and below were calculated and a systematic data base search was performed. The inherent problem of the MALDI-technique, the reduced sensitivity for low molecular weight substances caused by matrix suppression effects, was reduced by our technique. We identified several nucleosides in urine, which were previously identified via retention times and UV spectra of standards after HPLC analysis. Eight further nucleosides were observed. This work demonstrates for the first time the potential of MALDI-TOF and PSD-MALDI in combination with semipreparative HPLC for assignment of nucleosides in urine. The particularly high mass accuracy of this mass spectrometric method provides opportunities for identifying unknown compounds.
authors.affiliation: Institute of Pharmacology and Toxicology, Division of Clinical Pharmacology, University Hospital Tübingen, Otfried-Müller Strasse 45, D-72076 Tübingen, Germany. Bernd.Kammerer@uni-tuebingen.de
authors.forename: Bernd
authors.initials: B
authors.lastname: Kammerer
authors.forename: Antje
authors.initials: A
authors.lastname: Frickenschmidt
authors.forename: Christoph H
authors.initials: CH
authors.lastname: Gleiter
authors.forename: Stefan
authors.initials: S
authors.lastname: Laufer
authors.forename: Hartmut
authors.initials: H
authors.lastname: Liebich
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002138:Calibration; D006801:Humans; D007553:Isotope Labeling; D015394:Molecular Structure; D009705:Nucleosides / Q000652:urine*; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D013329:Structure-Activity Relationship
chemical_list: D009705:Nucleosides